In addition, it reduced mesenchymal markers (N-cadherin and snail) and increased epithelial markers (E-cadherin and claudin-1) in A549 cells (Figure 8C), suggesting that B5 can reduce tumor migration through modulated mesenchymal–epithelial transition in NSCLC. The gene discussed is CLDN1; the disease is non-small cell lung carcinoma.